Purchase Order SPE2DP26V0406

Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...

The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant, with a ceiling value of $3,462. The award, issued on July 31, 2018, with an ultimate completion date of August 6, 2018, represents a routine consumable procurement for military medical supply operations. No set-aside designation was used for this acquisition, reflecting Fenwal's established position as a qualified supplier of specialized blood products...

<p>Fenwal, Inc. has been awarded a $7,356.16 firm fixed price purchase order by the Defense Logistics Agency Troop Support Medical to deliver blood packs with anticoagulant. As a global blood technology company and manufacturer of goods, Fenwal will provide the requested blood collection products from its Lake Zurich, Illinois place of performance by September 25, 2023. No set aside designation was associated with this contract award to support the agency's medical supply needs.</p>

This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The contract is for the supply of a blood pack with an anticoagulant, with a ceiling value of $1,101.28 and an ultimate completion date of August 4, 2025. The contract does not have a set-aside designation. Fenwal, Inc. is a registered vendor with the U.S. federal government,...

The Defense Logistics Agency Medical Supply Chain awarded a $3,581.75 firm fixed-price purchase order to Fenwal, Inc. for washing solution on January 27, 2026, with an ultimate completion date of May 27, 2026. This contract carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for this critical blood banking consumable. Fenwal, a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, is a global blood technology company that...

The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order valued at $3,967.24 to Fenwal, Inc. for a hand blood sealer on November 7, 2025, with an ultimate completion date of December 1, 2025. The contract, issued without set-aside designation, reflects Fenwal's established position as a specialized supplier of blood collection, separation, storage, and transfusion products to federal health agencies. Fenwal, a subsidiary of Fresenius Kabi headquartered...

Fenwal, Inc., a Lake Zurich, Illinois-based blood technology manufacturer and subsidiary of Fresenius Kabi, has been awarded a firm fixed-price purchase order valued at $1,214.16 by the Defense Logistics Agency Medical Supply Chain for Anticoagulant Citra products. The contract, awarded January 27, 2026, carries an ultimate completion date of February 11, 2026, and was issued without a set-aside designation, reflecting Fenwal's specialized capabilities in transfusion medicine. As the prime...

The U.S. Department of Defense's Medical Supply Chain awarded a firm fixed-price purchase order valued at $11,486.50 to Fenwal, Inc. for blood collection assemblies. The contract was executed on September 25, 2025, with an ultimate completion date of September 30, 2025. No set-aside designation was applied to this award. Fenwal, Inc., a subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, serves as the prime contractor and will perform all work at its Illinois facility. Fenwal,...

The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on March 25, 2025, for the supply of intravenous fluids for blood bank operations. Valued at $16,608.88 with an ultimate completion date of September 1, 2025, this contract represents a non-set-aside award supporting critical blood banking capabilities. Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi headquartered in Lake Zurich, Illinois, will perform this work at Agana...

The Defense Health Agency awarded a firm fixed-price purchase order to Fenwal, Inc. on December 1, 2025, for the supply of frozen blood, blood collection bags, and glycerolyte 57% solutions. The contract, valued at $237,718.20 with an ultimate completion date of September 30, 2026, will be performed at Camp Lejeune, North Carolina. This award carries no set-aside designation, reflecting Fenwal's specialized capabilities as the sole source provider for these critical blood banking consumables and...